maslinic acid has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Dong, XL; Du, ZR; Li, C; Liu, JR; Liu, X; Wang, X; Wong, KH; Xu, PY; Ye, JL; Zhao, F; Zhao, Q; Zhou, SN | 1 |
1 other study(ies) available for maslinic acid and Parkinson Disease
| Article | Year |
|---|---|
Low and high doses of oral maslinic acid protect against Parkinson's disease via distinct gut microbiota-related mechanisms.
Topics: Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Parkinson Disease; Substantia Nigra | 2023 |